MedPath
NMPA Approval

Almagate Suspension

国药准字H10980322

April 8, 2020

Drug Information

铝镁加混悬液

安达

安达

口服混悬剂

15ml:1.5g

化学药品

April 8, 2020

Company Information

Applicant Company

江苏省高邮市长兴路8号

Manufacturing Company

江苏省高邮市长兴路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

铝镁加混悬液 - NMPA 批准文号 | MedPath